US Stock MarketDetailed Quotes

KEY KeyCorp

Watchlist
  • 15.160
  • -0.570-3.62%
Close Mar 10 16:00 ET
  • 15.230
  • +0.070+0.46%
Post 20:01 ET
16.75BMarket Cap-47.38P/E (TTM)

KeyCorp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KeyCorp Q4 2024 Earnings Date

Currency：USDJan 21, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.75B
793.00M
-955.15M
Miss Est.
+13.66%
-46.67%
-54.64%
EPS
0.33
-0.28
-0.61
Miss Est.
+984.67%
-1033.33%
-186.05%
Analyst Rating
Buy

Mar 10, 2025

KeyCorp Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Jul 22, 20252025/Q2-- / 1.816B--
Apr 17, 20252025/Q1-- / 1.770B--
Jan 21, 20252024/Q4865.000M / 1.748B--
Oct 17, 20242024/Q3695.000M / 1.608B--
Jul 18, 20242024/Q21.526B / 1.527B--
DatePeriodRevenue/EstimateEarnings Call
Jul 22, 20252025/Q2-- / 1.816B--
Apr 17, 20252025/Q1-- / 1.770B--
Jan 21, 20252024/Q4865.000M / 1.748B--
Oct 17, 20242024/Q3695.000M / 1.608B--
Jul 18, 20242024/Q21.526B / 1.527B--

Unlock Free Earnings Estimates

KeyCorp Earnings Reports

  • KeyCorp | 10-K: FY2024 Annual Report

    Feb 21 15:57 ET

  • KeyCorp | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 15:12 ET

  • KeyCorp | 10-Q: Q2 2024 Earnings Report

    Jul 26, 2024 14:54 ET

  • KeyCorp | 10-Q: Q1 2024 Earnings Report

    May 2, 2024 16:46 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +3.45%
    Collegium Pharmaceutical
    COLL
    +2.59%
    Constellation Brands
    STZ
    +1.73%
    Halozyme Therapeutics
    HALO
    +0.75%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 10, 2025

    Buy

    • Buy

      63.64%

    • Hold

      36.36%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Asset Management
    Asset Management
    Intraday-4.20%